Stammdaten
Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.
Unternehmen & Branche
| Name | Turn Therapeutics Inc. |
|---|---|
| Ticker | TTRX |
| CIK | 0002023016 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 103,1 Mio. USD |
| Beta | 1,56 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -3,194,080 | -0.12 | 12,162,241 | 4,686,723 | |
| 2025-09-30 | 10-Q | -1,904,184 | -0.07 | 4,297,630 | 504,019 | |
| 2024-12-31 | 10-K | -1,768,415 | -0.07 | 2,048,889 | -177,432 | |
| 2024-09-30 | 10-Q | -666,442 | -0.03 | -414,299 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | Chaudhary Zuraiz | Officer, See Remarks | Open Market Purchase | 2,500 | 3.50 | 8,750.00 | +28,8% | |
| 2025-11-24 | GOLDEN ARTHUR F | Director | Open Market Purchase | 9,868 | 3.44 | 33,945.92 | +111,9% | |
| 2025-11-21 | Chaudhary Zuraiz | Officer, See Remarks | Open Market Purchase | 1,000 | 3.29 | 3,290.00 | +10,8% | |
| 2025-11-21 | GOLDEN ARTHUR F | Director | Open Market Purchase | 20,532 | 2.87 | 58,926.84 | +194,2% | |
| 2025-11-20 | Chaudhary Zuraiz | Officer, See Remarks | Open Market Purchase | 1,450 | 2.61 | 3,784.50 | +12,5% | |
| 2025-11-17 | Chaudhary Zuraiz | Officer, See Remarks | Open Market Purchase | 2,500 | 3.62 | 9,050.00 | +29,8% | |
| 2025-10-23 | GOLDEN ARTHUR F | Director | Open Market Purchase | 20,202 | 4.95 | 99,999.90 | +329,6% | |
| 2025-10-23 | Chaudhary Zuraiz | Officer, See Remarks | Open Market Purchase | 5,050 | 4.95 | 24,997.50 | +82,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.